CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended		181 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013
Cash flows from operating activities:
Net income (loss)	$ 185,700	$ (1,825,900)	$ (67,483,500)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	12,200	5,900	789,700
Acquired in-process research and development			7,523,200
Amortization of imputed discount on non-interest bearing notes			45,000
Amortization of discounts on 7%, 7.5% and 10% notes	78,000	20,900	551,700
Amortization of discounts on Platinum notes	16,000		3,578,100
Amortization of discounts on August 2010 short-term notes			572,000
Amortization of discounts on February 2012 12% convertible notes		9,800	22,700
Loss (gain) on currency fluctuation	17,400	(55,500)	(35,600)
Loss on early extinguishment of debt			4,761,300
Loss on settlements of accounts payable			78,300
Change in warrant and put and note term extension option liabilities	(1,804,900)		(587,700)
Stock-based compensation	198,100	71,000	5,793,700
Expense related to modification of warrants	(34,500)	436,400	1,215,400
Fair value of Series C preferred stock, common stock, and warrants granted for services			925,400
Fair value of common stock granted for services prior to the Merger			2,225,500
Fair value of common stock granted for services following the Merger		26,200	792,000
Fair value of warrants granted for services following the Merger	22,500	19,300	770,800
Fair value of additional warrants granted pursuant to exercises of modified warrants (May-August 2012) and under Discounted Warrant Exercise Program (2011)		34,800	174,000
Fair value of common stock issued for note term modification			22,400
Interest income on note receivable for stock purchase	(2,500)		(30,100)
Consulting services by related parties settled by issuing promissory notes			44,600
Gain on sale of assets			(16,800)
Changes in operating assets and liabilities:
Unbilled contract payments receivable		106,200
Prepaid expenses and other current assets	(36,100)	(3,700)	5,600
Security deposits and other assets			(29,000)
Accounts payable and accrued expenses	616,300	871,600	16,587,800
Deferred revenues		(13,200)
Net cash used in operating activities	(731,800)	(296,200)	(21,703,500)
Cash flows from investing activities:
Purchases of equipment, net	9,600		825,800
Net cash used in investing activities	9,600		825,800
Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants, including units	57,000		4,042,100
Net proceeds from issuance of preferred stock and warrants			4,198,600
Proceeds from exercise of modified warrants	178,700	257,300	1,607,100
Proceeds from issuance of notes under line of credit			200,000
Proceeds from issuance of 7% note payable to founding stockholder			90,000
Net proceeds from issuance of 7% convertible notes			575,000
Net proceeds from issuance of 10% convertible notes and warrants			1,655,000
Net proceeds from issuance of Platinum notes and warrants			6,922,100
Net proceeds from issuance of 2008/2010 notes and warrants			2,971,800
Net proceeds from issuance of 2006/2007 notes and warrants			1,025,000
Proceeds from issuance of 7% notes payable			55,000
Net proceeds from issuance of August 2010 short-term notes and warrants			800,000
Net proceeds from issuance of February 2012 12% convertible notes and warrants			466,500
Repayment of capital lease obligations	(1,900)	(5,700)	(119,300)
Repayment of notes	(40,700)	(4,700)	(1,869,800)
Net cash provided by financing activities	193,100	246,900	22,619,100
Net increase in cash and cash equivalents	(548,300)	(49,300)	89,800
Cash and cash equivalents at beginning of period	638,100	638,100
Cash and cash equivalents at end of period	$ 89,800	$ 31,700	$ 89,800